Media coverage of the 2019 United States Food and Drug Administration ordered withdrawal of vaginal mesh products for pelvic organ prolapse

Poone S. Shoureshi, Wai Lee, Kathleen C. Kobashi, Kamran P. Sajadi

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Introduction and hypothesis: On April 16, 2019, the United States Food and Drug Administration announced a withdrawal on sales and distribution of transvaginal mesh products for pelvic organ prolapse. The aim of this study was to asses online user behavior on pelvic-mesh related articles after the withdrawal and to evaluate article accuracy. Materials and methods: We used Google Trends

Original languageEnglish (US)
Pages (from-to)375-379
Number of pages5
JournalInternational Urogynecology Journal
Volume32
Issue number2
DOIs
StatePublished - Feb 2021

Keywords

  • FDA mesh
  • Pelvic organ prolapse
  • Transvaginal mesh
  • Vaginal mesh

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Urology

Fingerprint Dive into the research topics of 'Media coverage of the 2019 United States Food and Drug Administration ordered withdrawal of vaginal mesh products for pelvic organ prolapse'. Together they form a unique fingerprint.

Cite this